https://m2.mtmt.hu/ hun 2026-09-23 09:28 JournalArticle 34801051 VALIDATED true Export Date: 3 July 2024 CODEN: LANCA Correspondence Address: Kosiborod, M.N.; Department of Cardiovascular Disease, United States; email: mkosiborod@saint-lukes.org 0 false 2026-09-14T07:17:25.448+0000 2024-05-02T11:41:31.265+0000 2024-04-19T12:16:36.258+0000 true 10055096 Nagy Regina /api/admin/10055096 Admin Nagy Regina (SE_AOK_Városmajor_Kardiol_Szívseb_Admin5_NR, admin) true 10055096 2025-07-21T20:00:12.084+0000 2024-05-02T11:41:31.274+0000 true 10080205 Szalóky-Siki Ágnes /api/admin/10080205 Admin Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin) true true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000359 Study Group true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000359 Sokszerzős vagy csoportos szerzőségű szakcikk SubType Sokszerzős vagy csoportos szerzőségű szakcikk (Folyóiratcikk) 104 true 10000359 true 1 /api/category/1 Category Tudományos true 1 Butler, Javed true true /api/journal/3012 REVIEWED LANCET 0140-6736 1474-547X true false 3012 false 3012 true 0140-6736 1474-547X Journal FOREIGN 403 10437 1635 1648 1635 14 2024 true true 2024 true true true false false NONE 2026-09-14 false 320 0 320 259 4 317 319 291 307 320 320 259 259 259 61 0 320 259 320 259 0 2 2 Folyóiratcikk Journal Article 24 317 Könyvrészlet Chapter in Book 25 3 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2023 0 1 1 1 1 2024 0 61 49 61 49 2025 0 165 127 165 127 2026 0 93 82 93 82 D1 A nemzetközi false false false false 2024-05-01T11:41:31.077+0000 Kardiológia Központ - Kardiológiai Tanszék (SE / AOK / K); Repülõ- és Űrorvostani Tanszék (SE / AOK / K); Sportorvostan Tanszék (SE / AOK / K); Városmajori Szív- és Érgyógyászati Klinika (SE / AOK / K) 1 26 4 32 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 116258409 /api/authorship/116258409 Butler, Javed 1 0.0 true false false Butler Javed true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258410 /api/authorship/116258410 Shah, Sanjiv J 2 0.0 false false false Shah Sanjiv J true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258411 /api/authorship/116258411 Petrie, Mark C 3 0.0 false false false Petrie Mark C true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258412 /api/authorship/116258412 Borlaug, Barry A 4 0.0 false false false Borlaug Barry A true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258413 /api/authorship/116258413 Abildstrøm, Steen Z 5 0.0 false false false Abildstrøm Steen Z true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258414 /api/authorship/116258414 Davies, Melanie J 6 0.0 false false false Davies Melanie J true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258415 /api/authorship/116258415 Hovingh, G Kees 7 0.0 false false false Hovingh G Kees true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258416 /api/authorship/116258416 Kitzman, Dalane W 8 0.0 false false false Kitzman Dalane W true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258417 /api/authorship/116258417 Møller, Daniél Vega 9 0.0 false false false Møller Daniél Vega true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258418 /api/authorship/116258418 Verma, Subodh 10 0.0 false false false Verma Subodh true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258419 /api/authorship/116258419 Einfeldt, Mette Nygaard 11 0.0 false false false Einfeldt Mette Nygaard true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258420 /api/authorship/116258420 Lindegaard, Marie L 12 0.0 false false false Lindegaard Marie L true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258421 /api/authorship/116258421 Rasmussen, Søren 13 0.0 false false false Rasmussen Søren true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258422 /api/authorship/116258422 Abhayaratna, Walter 14 0.0 false false false Abhayaratna Walter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258423 /api/authorship/116258423 Ahmed, Fozia Z 15 0.0 false false false Ahmed Fozia Z true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258424 /api/authorship/116258424 Ben-Gal, Tuvia 16 0.0 false false false Ben-Gal Tuvia true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258425 /api/authorship/116258425 Chopra, Vijay 17 0.0 false false false Chopra Vijay true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258426 /api/authorship/116258426 Ezekowitz, Justin A 18 0.0 false false false Ezekowitz Justin A true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258427 /api/authorship/116258427 Fu, Michael 19 0.0 false false false Fu Michael true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258428 /api/authorship/116258428 Ito, Hiroshi 20 0.0 false false false Ito Hiroshi true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258429 /api/authorship/116258429 Lelonek, Małgorzata 21 0.0 false false false Lelonek Małgorzata true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258430 /api/authorship/116258430 Melenovský, Vojtěch 22 0.0 false false false Melenovský Vojtěch true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258431 /api/authorship/116258431 Merkely, Bela [Merkely, Béla Péter (Kardiológia), szerző] Városmajori Szív- és Érgyógyászati Klinika (SE / AOK / K); Kardiológia Központ - Kardiológiai Tanszék (SE / AOK / K); Sportorvostan Tanszék (SE / AOK / K); Repülõ- és Űrorvostani Tanszék (SE / AOK / K) 23 0.0 false false false Author 10002691 /api/author/10002691 Merkely Béla Péter (Kardiológia) Merkely Béla Péter true 10002691 true Merkely Bela true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258432 /api/authorship/116258432 Núñez, Julio 24 0.0 false false false Núñez Julio true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258433 /api/authorship/116258433 Perna, Eduardo 25 0.0 false false false Perna Eduardo true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258434 /api/authorship/116258434 Schou, Morten 26 0.0 false false false Schou Morten true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258435 /api/authorship/116258435 Senni, Michele 27 0.0 false false false Senni Michele true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258436 /api/authorship/116258436 Sharma, Kavita 28 0.0 false false false Sharma Kavita true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258437 /api/authorship/116258437 van der Meer, Peter 29 0.0 false false false van der Meer Peter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258438 /api/authorship/116258438 Von Lewinski, Dirk 30 0.0 false false false Von Lewinski Dirk true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258439 /api/authorship/116258439 Wolf, Dennis 31 0.0 false false false Wolf Dennis true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 116258440 /api/authorship/116258440 Kosiborod, Mikhail N ✉ 32 0.0 false true true Kosiborod Mikhail N true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true OrgAuthorship 116461991 /api/authorship/116461991 the STEP-HFpEF Trial Committees and Investigators [Kollaborációs szervezet] 33 0.0 false false true false false AuthorshipType 30 /api/authorshiptype/30 Kollaborációs szervezet -29 true -29 true false true PublicationIdentifier 26034952 /api/publicationidentifier/26034952 DOI: 10.1016/S0140-6736(24)00469-0 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1016/S0140-6736(24)00469-0 https://doi.org/10.1016/S0140-6736%2824%2900469-0 false true PublicationIdentifier 26651049 /api/publicationidentifier/26651049 WoS: 001236875200001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001236875200001 https://www.webofscience.com/wos/woscc/full-record/001236875200001 false true PublicationIdentifier 26122942 /api/publicationidentifier/26122942 Scopus: 85190955005 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85190955005 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85190955005 true true PublicationIdentifier 26122943 /api/publicationidentifier/26122943 PubMed: 38599221 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 38599221 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38599221&dopt=Abstract true true MtaRating 11507983 /api/mtarating/11507983 IX. Demográfiai Osztályközi Állandó Bizottság:A nemzetközi LANCET 0140-6736 1474-547X RatingType 10011 /api/ratingtype/10011 IX. Demográfiai Osztályközi Állandó Bizottság DEM Institute 19060 /api/institute/19060 Demográfiai Osztályközi Állandó Bizottság IXGJO DEM [1901-] 0 false true false Demográfiai Osztályközi Állandó Bizottság Committee on Demography true 19060 true true true A nemzetközi false true MtaRating 519059 /api/mtarating/519059 IX. Szociológiai Tudományos Bizottság:A nemzetközi LANCET 0140-6736 1474-547X RatingType 10007 /api/ratingtype/10007 IX. Szociológiai Tudományos Bizottság SZTB Institute 14102 /api/institute/14102 Szociológiai Tudományos Bizottság IXGJO SZTB [1901-] 0 false true false Szociológiai Tudományos Bizottság Committee on Sociology true 14102 true true true A nemzetközi true 19059 true SjrRating 11482524 /api/sjrrating/11482524 sjr:D1 (2024) Scopus - Medicine (miscellaneous) LANCET 0140-6736 1474-547X 11 0.0 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2701 /api/classificationexternal/2701 Scopus - Medicine (miscellaneous) true 2701 true D1 DIRECT true true Reference 52081299 /api/reference/52081299 1. Shah 2020: Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute Working Group summary., Circulation, 141, p. 1001, DOI: 10.1161/CIRCULATIONAHA.119.041886 1 10.1161/CIRCULATIONAHA.119.041886 false true Reference 52081300 /api/reference/52081300 2. Pandey 2017: Relationship between physical activity, body mass index, and risk of heart failure., J Am Coll Cardiol, 69, p. 1129, DOI: 10.1016/j.jacc.2016.11.081 2 10.1016/j.jacc.2016.11.081 false true Reference 52081301 /api/reference/52081301 3. Shah 2022: BNP: biomarker not perfect in heart failure with preserved ejection fraction., Eur Heart J, 43, p. 1952, DOI: 10.1093/eurheartj/ehac121 3 10.1093/eurheartj/ehac121 false true Reference 52081302 /api/reference/52081302 4. Lindman 2014: Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study., J Am Coll Cardiol, 64, p. 541, DOI: 10.1016/j.jacc.2014.05.030 4 10.1016/j.jacc.2014.05.030 false true Reference 52081303 /api/reference/52081303 5. McHugh 2019: Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review., J Am Coll Cardiol, 73, p. 602, DOI: 10.1016/j.jacc.2018.11.033 5 10.1016/j.jacc.2018.11.033 false true Reference 52081304 /api/reference/52081304 6. De Marco 2021: Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial., ESC Heart Fail, 8, p. 1130, DOI: 10.1002/ehf2.13153 6 10.1002/ehf2.13153 false true Reference 52081305 /api/reference/52081305 7. Paulus 2013: A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation., J Am Coll Cardiol, 62, p. 263, DOI: 10.1016/j.jacc.2013.02.092 7 10.1016/j.jacc.2013.02.092 false true Reference 52081306 /api/reference/52081306 8. Shah 2018: Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF., Eur Heart J, 39, p. 3439, DOI: 10.1093/eurheartj/ehy531 8 10.1093/eurheartj/ehy531 false true Reference 52081307 /api/reference/52081307 9. Obokata 2017: Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction., Circulation, 136, p. 6, DOI: 10.1161/CIRCULATIONAHA.116.026807 9 10.1161/CIRCULATIONAHA.116.026807 false true Reference 52081308 /api/reference/52081308 10. Packer 2018: Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium., J Am Coll Cardiol, 71, p. 2360, DOI: 10.1016/j.jacc.2018.03.509 10 10.1016/j.jacc.2018.03.509 false true Reference 52081309 /api/reference/52081309 11. Miller 2020: Impact of obesity on volume status in patients with ambulatory chronic heart failure., J Card Fail, 26, p. 112, DOI: 10.1016/j.cardfail.2019.09.010 11 10.1016/j.cardfail.2019.09.010 false true Reference 52081310 /api/reference/52081310 12. Sorimachi 2021: Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction., Eur J Heart Fail, 23, p. 1648, DOI: 10.1002/ejhf.2254 12 10.1002/ejhf.2254 false true Reference 52081311 /api/reference/52081311 13. Kosiborod 2023: Semaglutide in patients with heart failure with preserved ejection fraction and obesity., N Engl J Med, 389, p. 1069, DOI: 10.1056/NEJMoa2306963 13 10.1056/NEJMoa2306963 false true Reference 52081312 /api/reference/52081312 14. Wilding 2021: Once-weekly semaglutide in adults with overweight or obesity., N Engl J Med, 384, p. 989, DOI: 10.1056/NEJMoa2032183 14 10.1056/NEJMoa2032183 false true Reference 52081313 /api/reference/52081313 15. Davies 2021: Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial., Lancet, 397, p. 971, DOI: 10.1016/S0140-6736(21)00213-0 15 10.1016/S0140-6736(21)00213-0 false true Reference 52081314 /api/reference/52081314 16. Jastreboff 2022: Tirzepatide once weekly for the treatment of obesity., N Engl J Med, 387, p. 205, DOI: 10.1056/NEJMoa2206038 16 10.1056/NEJMoa2206038 false true Reference 52081315 /api/reference/52081315 17. Garvey 2023: Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial., Lancet, 402, p. 613, DOI: 10.1016/S0140-6736(23)01200-X 17 10.1016/S0140-6736(23)01200-X false true Reference 52081316 /api/reference/52081316 18. Kosiborod 2023: Design and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF phenotype., JACC Heart Fail, 11, p. 1000, DOI: 10.1016/j.jchf.2023.05.010 18 10.1016/j.jchf.2023.05.010 false true Reference 52081317 /api/reference/52081317 19. Kosiborod 2024: Semaglutide in patients with obesity-related heart failure and type 2 diabetes., N Engl J Med, DOI: 10.1056/NEJMoa2313917 19 10.1056/NEJMoa2313917 false true Reference 52081318 /api/reference/52081318 20. Green 2000: Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure., J Am Coll Cardiol, 35, p. 1245, DOI: 10.1016/S0735-1097(00)00531-3 20 10.1016/S0735-1097(00)00531-3 false true Reference 52081319 /api/reference/52081319 21. Joseph 2013: Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction., Circ Heart Fail, 6, p. 1139, DOI: 10.1161/CIRCHEARTFAILURE.113.000359 21 10.1161/CIRCHEARTFAILURE.113.000359 false true Reference 52081320 /api/reference/52081320 22. Spertus 2020: Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review., J Am Coll Cardiol, 76, p. 2379, DOI: 10.1016/j.jacc.2020.09.542 22 10.1016/j.jacc.2020.09.542 false true Reference 52081321 /api/reference/52081321 23. Higgins 2002: Quantifying heterogeneity in a meta-analysis., Stat Med, 21, p. 1539, DOI: 10.1002/sim.1186 23 10.1002/sim.1186 false true Reference 52081322 /api/reference/52081322 24. Wisniewski 2016: Good signal detection practices: evidence from IMI PROTECT., Drug Saf, 39, p. 469, DOI: 10.1007/s40264-016-0405-1 24 10.1007/s40264-016-0405-1 false true Reference 52081323 /api/reference/52081323 25. Kosiborod 2023: Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses., Diabetes Obes Metab, 25, p. 468, DOI: 10.1111/dom.14890 25 10.1111/dom.14890 false true Reference 52081324 /api/reference/52081324 26. Lincoff 2023: Semaglutide and cardiovascular outcomes in obesity without diabetes., N Engl J Med, 389, p. 2221, DOI: 10.1056/NEJMoa2307563 26 10.1056/NEJMoa2307563 false true Reference 52081325 /api/reference/52081325 27. Marso 2016: Semaglutide and cardiovascular outcomes in patients with type 2 diabetes., N Engl J Med, 375, p. 1834, DOI: 10.1056/NEJMoa1607141 27 10.1056/NEJMoa1607141 false true Reference 52081326 /api/reference/52081326 28. Rentzeperi 2022: Sex differences in response to treatment with glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care., J Pers Med, 12, p. 454, DOI: 10.3390/jpm12030454 28 10.3390/jpm12030454 false true Reference 52081327 /api/reference/52081327 29. Margulies 2016: Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial., JAMA, 316, p. 500, DOI: 10.1001/jama.2016.10260 29 10.1001/jama.2016.10260 false true Reference 52081328 /api/reference/52081328 30. Jorsal 2017: Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial., Eur J Heart Fail, 19, p. 69, DOI: 10.1002/ejhf.657 30 10.1002/ejhf.657 false true Reference 52081329 /api/reference/52081329 31. Altara 2017: Targeting obesity and diabetes to treat heart failure with preserved ejection fraction., Front Endocrinol, 8, p. 160, DOI: 10.3389/fendo.2017.00160 31 10.3389/fendo.2017.00160 false true Reference 52081330 /api/reference/52081330 32. Chaar 2022: Neutrophils and circulating inflammatory biomarkers in diabetes mellitus and heart failure with preserved ejection fraction., Am J Cardiol, 178, p. 80, DOI: 10.1016/j.amjcard.2022.05.026 32 10.1016/j.amjcard.2022.05.026 false true Reference 52081331 /api/reference/52081331 33. Kitzman 2018: Pivotal role of excess intra-abdominal adipose in the pathogenesis of metabolic/obese HFpEF., JACC Heart Fail, 6, p. 1008, DOI: 10.1016/j.jchf.2018.08.007 33 10.1016/j.jchf.2018.08.007 false true Reference 52081332 /api/reference/52081332 34. Salvatore 2022: Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes., Biomolecules, 12, p. 176, DOI: 10.3390/biom12020176 34 10.3390/biom12020176 false true Reference 52081333 /api/reference/52081333 35. Borlaug 2023: Heart failure with preserved ejection fraction: JACC scientific statement., J Am Coll Cardiol, 81, p. 1810, DOI: 10.1016/j.jacc.2023.01.049 35 10.1016/j.jacc.2023.01.049 false true Reference 52081334 /api/reference/52081334 36. Kosiborod 2023: Semaglutide and heart failure with preserved ejection fraction and obesity. Reply., N Engl J Med, 389, p. 2398, DOI: 10.1056/NEJMoa2306963 36 10.1056/NEJMoa2306963 false true Reference 52081335 /api/reference/52081335 37. Verma 2024: Obesity/cardiometabolic phenotype of heart failure with preserved ejection fraction: mechanisms to recent trials., Curr Opin Cardiol, 39, p. 92, DOI: 10.1097/HCO.0000000000001113 37 10.1097/HCO.0000000000001113 false true Reference 52081336 /api/reference/52081336 38. Bertoni 2012: Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes., Obesity, 20, p. 1511, DOI: 10.1038/oby.2011.296 38 10.1038/oby.2011.296 false true Reference 52081337 /api/reference/52081337 39. Goldney 2023: Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy., Diabetologia, 66, p. 1832, DOI: 10.1007/s00125-023-05988-3 39 10.1007/s00125-023-05988-3 false true Reference 52081338 /api/reference/52081338 40. Withaar 2023: The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF., JACC Basic Transl Sci, 8, p. 1298, DOI: 10.1016/j.jacbts.2023.05.012 40 10.1016/j.jacbts.2023.05.012 false true Reference 52081339 /api/reference/52081339 41. Garvey 2022: Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial., Nat Med, 28, p. 2083, DOI: 10.1038/s41591-022-02026-4 41 10.1038/s41591-022-02026-4 false true Reference 52081340 /api/reference/52081340 42. Shi 2015: Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways., Cardiovasc Diabetol, 14, p. 18, DOI: 10.1186/s12933-015-0177-4 42 10.1186/s12933-015-0177-4 false true Reference 52081341 /api/reference/52081341 43. Ma 2021: GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential., Int J Biol Sci, 17, p. 2050, DOI: 10.7150/ijbs.59965 43 10.7150/ijbs.59965 false true Reference 52081342 /api/reference/52081342 44. Mazidi 2017: Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials., J Diabetes Complications, 31, p. 1237, DOI: 10.1016/j.jdiacomp.2016.05.022 44 10.1016/j.jdiacomp.2016.05.022 false true Reference 52081343 /api/reference/52081343 45. Oh 2017: Effects of glucagon-like peptide-1 on oxidative stress and Nrf2 signaling., Int J Mol Sci, 19, p. 26, DOI: 10.3390/ijms19010026 45 10.3390/ijms19010026 false true Reference 52081344 /api/reference/52081344 46. Puglisi 2021: Effects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system., Front Endocrinol, 12, DOI: 10.3389/fendo.2021.738848 46 10.3389/fendo.2021.738848 false true Reference 52081345 /api/reference/52081345 47. Forman 2017: Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease: a scientific statement for healthcare professionals from the American Heart Association., Circulation, 135, p. e894, DOI: 10.1161/CIR.0000000000000483 47 10.1161/CIR.0000000000000483 false true Reference 52081346 /api/reference/52081346 48. Reed 2019: Patients' willingness to accept mitral valve procedure-associated risks varies across severity of heart failure symptoms., Circ Cardiovasc Interv, 12, DOI: 10.1161/CIRCINTERVENTIONS.119.008051 48 10.1161/CIRCINTERVENTIONS.119.008051 false true Reference 52081347 /api/reference/52081347 49. Lewis 2001: Preferences for quality of life or survival expressed by patients with heart failure., J Heart Lung Transplant, 20, p. 1016, DOI: 10.1016/S1053-2498(01)00298-4 49 10.1016/S1053-2498(01)00298-4 false true Reference 52081348 /api/reference/52081348 50. 2022: Treatment for heart failure: endpoints for drug development guidance for industry June 2019 50 false true /api/publication/34801051 Butler Javed et al. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials. (2024) LANCET 0140-6736 1474-547X 403 10437 1635-1648<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" >Butler Javed </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10002691"><a href="/gui2/?type=authors&mode=browse&sel=10002691" target="_blank">Merkely Bela (<span class="authorship-author-name">Merkely Béla Péter</span> <span class="authorAux-mtmt"> Kardiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Városmajori Szív- és Érgyógyászati Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Városmajori Szív- és Érgyógyászati Klinika">VAROSMAJOR_SZÍVÉRGYÓGY</span>/Kardiológia Központ - Kardiológiai Tanszék; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Városmajori Szív- és Érgyógyászati Klinika">VAROSMAJOR_SZÍVÉRGYÓGY</span>/Sportorvostan Tanszék; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Városmajori Szív- és Érgyógyászati Klinika">VAROSMAJOR_SZÍVÉRGYÓGY</span>/Repülõ- és Űrorvostani Tanszék</span> ;&nbsp;&nbsp;&nbsp; et al. (32) </div> <div class="autype autype-29"> Kollaborációs szervezet: <span class="author-affil">the STEP-HFpEF Trial Committees and Investigators</span> </div> <div><a target="_blank" href="/api/publication/34801051?labelLang=hun">Összes szerző</a></div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;34801051" target="_blank">Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials</a></div> <div> <span class="journal-title">LANCET</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0140-6736">0140-6736</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1474-547X">1474-547X</a>)</span>: <span class="journal-volume">403</span> <span class="journal-issue">10437</span> <span class="page"> pp 1635-1648 </span> <span class="year">(2024)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1016/S0140-6736(24)00469-0" target="_blank" href="https://doi.org/10.1016/S0140-6736%2824%2900469-0"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001236875200001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001236875200001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85190955005" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85190955005"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="38599221" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38599221&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Demográfiai Osztályközi Állandó Bizottság IXGJO DEM [1901-]&nbsp;&nbsp;&nbsp;A nemzetközi</div> <div class="journal-subject">Szociológiai Tudományos Bizottság IXGJO SZTB [1901-]&nbsp;&nbsp;&nbsp;A nemzetközi</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 320</span> | Független: 259 | Függő: 61 | Nem jelölt: 0 | WoS jelölt: 291 | Scopus jelölt:&nbsp;307 | WoS/Scopus jelölt:&nbsp;320 | DOI jelölt:&nbsp;319 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;34801051&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 2 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 34801051</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Sokszerzős vagy csoportos szerzőségű szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2024.05.02. 13:41 Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Export Date: 3 July 2024 CODEN: LANCA Correspondence Address: Kosiborod, M.N.; Department of Cardiovascular Disease, United States; email: mkosiborod@saint-lukes.org</pre> </div></div>